Display Settings:

Format

Send to:

Choose Destination
    Harm Reduct J. 2006 Jul 21;3:20.

    Expansion of opiate agonist treatment: an historical perspective.

    Source

    The Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center, Albert Einstein College of Medicine of Yeshiva University, 555 West 57th Street, 18th Floor, New York, NY 10019, USA. rnewman@icaat.org

    Abstract

    Untreated opiate addiction remains a major health care crisis in New York and in most other urban centers in America. Optimism for closing the gap between need and demand for treatment and its availability has greeted the recent approval of a new opiate medication for addiction, buprenorphine--which unlike methadone may be prescribed by independent, office-based practitioners. The likelihood of buprenorphine fulfilling its potential is assessed in the light of the massive expansion of methadone treatment more than 30 years earlier. It is concluded that the key, indispensable ingredient of success will be true commitment on the part of Government to provide care to all those who need it.

    PMID:
    16859549
    [PubMed]
    PMCID: PMC1557846
    Free PMC Article

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk